Literature DB >> 20683020

Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in endometrial cancer.

Darius Salehin1, Iris Fromberg, Christina Haugk, Birgit Dohmen, Thomas Georg, Rainer Maria Bohle, Dirk Bauerschlag, Nicolai Maass, Michael Friedrich.   

Abstract

BACKGROUND: Calpains (CAPN) are intracellular, non-lysosomal cytoplasmic cysteine endopeptidases and they are expressed ubiquitously. Their endogenous specific inhibitor is calpastatin. When calcium is present, calpastatin and calpain attach to each other, inhibiting the protease. The calpain system plays an important role in many processes including apoptosis, necrosis, ischaemia and exocytosis. The role of calpains in pathogenesis or further tumour progression has been proved in related studies. This study focused on the expression of the enzymes calpain 1, calpain 2 and the inhibitor calpastatin in normal and malignant endometrial tissue.
MATERIALS AND METHODS: Immunohistochemical stainings were performed on paraffin slices and staining intensity, percentage of positive cells and international ratio score were evaluated. RESULTS AND
CONCLUSION: The endometrial carcinoma showed a higher expression of calpastatin than benign endometrial tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683020

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.

Authors:  Jirong Long; Wei Zheng; Yong-Bing Xiang; Felicity Lose; Deborah Thompson; Ian Tomlinson; Herbert Yu; Nicolas Wentzensen; Diether Lambrechts; Thilo Dörk; Natalia Dubrowinskaja; Marc T Goodman; Helga B Salvesen; Peter A Fasching; Rodney J Scott; Ryan Delahanty; Ying Zheng; Tracy O'Mara; Catherine S Healey; Shirley Hodgson; Harvey Risch; Hannah P Yang; Frederic Amant; Nurzhan Turmanov; Anita Schwake; Galina Lurie; Jone Trovik; Matthias W Beckmann; Katie Ashton; Bu-Tian Ji; Ping-Ping Bao; Kimberly Howarth; Lingeng Lu; Jolanta Lissowska; Lieve Coenegrachts; Dilyara Kaidarova; Matthias Dürst; Pamela J Thompson; Camilla Krakstad; Arif B Ekici; Geoffrey Otton; Jiajun Shi; Ben Zhang; Maggie Gorman; Louise Brinton; An Coosemans; Rayna K Matsuno; Mari K Halle; Alexander Hein; Anthony Proietto; Hui Cai; Wei Lu; Alison Dunning; Douglas Easton; Yu-Tang Gao; Qiuyin Cai; Amanda B Spurdle; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

2.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 4.  Calpains as potential anti-cancer targets.

Authors:  Ludovic Leloup; Alan Wells
Journal:  Expert Opin Ther Targets       Date:  2011-01-19       Impact factor: 6.902

5.  An eleven autophagy-related genes-based prognostic signature for endometrial carcinoma.

Authors:  Shiyang Li; Junan Pan; Yanyu Zhang; Yan Tang; Xiaobing Zeng; Shihai Wang; Dengxuan Wu; Yuyong Liu; Dawen Xu; Jianjun Lan; Dong Hu
Journal:  J Egypt Natl Canc Inst       Date:  2022-10-10

6.  Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.

Authors:  Katarzyna Starska; Ewa Forma; Paweł Jóźwiak; Iwona Lewy-Trenda; Marian Danilewicz; Olga Stasikowska-Kanicka; Michał Skóra; Katarzyna Kolary; Jakub Miazga; Anna Krześlak; Magdalena Bryś
Journal:  Tumour Biol       Date:  2016-07-25

7.  High level of calpain1 promotes cancer cell invasion and migration in oral squamous cell carcinoma.

Authors:  Da Ma; Juan Fang; Ying Liu; Jing-Jing Song; Yan-Qiong Wang; Juan Xia; Bin Cheng; Zhi Wang
Journal:  Oncol Lett       Date:  2017-04-03       Impact factor: 2.967

8.  Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index.

Authors:  Shadia M Al-Bahlani; Ruqaya M Al-Rashdi; Shiyam Kumar; Shadia S Al-Sinawi; Maiya A Al-Bahri; Asem A Shalaby
Journal:  Biomed Res Int       Date:  2017-04-27       Impact factor: 3.411

9.  The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.

Authors:  Quentin Raimbourg; Joëlle Perez; Sophie Vandermeersch; Aurélie Prignon; Guillaume Hanouna; Jean-Philippe Haymann; Laurent Baud; Emmanuel Letavernier
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma.

Authors:  Emily A Bassett; Kamalakannan Palanichamy; Mitchell Pearson; Joseph P McElroy; Saikh Jaharul Haque; Erica Hlavin Bell; Arnab Chakravarti
Journal:  Oncotarget       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.